2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults "Lipid Targets & Treatments 2014" Presented by Robert H. Eckel, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Divsion of Cardiology Professor of Physiology and Biophysics Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Robinson, J. G., & Stone, N. J. (2015). The 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk: A new paradigm supported by more evidence. Improving Guideline-Based Cholesterol Management in Your Patients. This activity provides physicians and nurses an opportunity to improve in managing their patients with CVD risk to LDL-cholesterol goals according to the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Disease (ASCVD) Risk in Adults. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Endorsed by the American Academy of Physician Assistants, American Association of 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Cholesterol Treatment Trialists' Collaborators Overview of 2013 ACC/AHA cholesterol guideline 1. Treat blood cholesterol to reduce ASCVD risk 2. Healthy lifestyle is the foundation for ASCVD risk reduction • Background therapy for all randomized controlled trials • ACC/AHA 2013 Lifestyle an